fda_approval · anda · info
RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified)
- Event date
- 2026-06-23 00:00:00Z
- Observed
- 2026-07-09 22:53:27Z
- Source ID
- ANDA220869-1
- Payload hash
- e79d2455120522fd1c4cd35d…
Summary
RUBICON RESEARCH received ANDA approval for PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified) on 2026-06-23. Dosage form: SYRUP. Application #: ANDA220869.
Entities
Frequently asked questions
- Has RUBICON RESEARCH had other FDA enforcement actions?
- Yes. Argus HQ has recorded 4 total FDA actions tied to RUBICON RESEARCH: 0 warning letters, 0 recalls, 4 approval records, and 0 Form 483 inspection citations.
- What kind of FDA record is this?
- This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-06-23; Argus observed and indexed it on 2026-07-09.
- Where can I verify this record directly with FDA?
- The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
APA
Argus HQ Research (2026). RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-rubicon-research-anda220869-1
MLA
"RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-rubicon-research-anda220869-1.
Chicago
Argus HQ Research. "RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified)." Digital Empire Holdings LLC. Accessed October 14, 2026. https://argushq.ai/events/fda-approval-rubicon-research-anda220869-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_rubicon_research_anda220869_1_2026,
title = {RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/events/fda-approval-rubicon-research-anda220869-1},
note = {Accessed: October 14, 2026}
}Informational only. Not legal, financial, or medical advice.

